Goldman Sachs’s AEON Biopharma AEON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-157
| Closed | -$11.9K | – | 4822 |
|
|
2024
Q2 | $11.9K | Sell |
157
-2,192
| -93% | -$166K | ﹤0.01% | 4631 |
|
|
2024
Q1 | $1.96M | Buy |
2,349
+2,091
| +810% | +$1.75M | ﹤0.01% | 3216 |
|
|
2023
Q4 | $134K | Sell |
258
-80
| -24% | -$41.4K | ﹤0.01% | 4414 |
|
|
2023
Q3 | $136K | Buy |
+338
| New | +$136K | ﹤0.01% | 4335 |
|
|
2023
Q1 | – | Sell |
-3,854
| Closed | -$2.79M | – | 5102 |
|
|
2022
Q4 | $2.79M | Hold |
3,854
| – | – | ﹤0.01% | 3048 |
|
|
2022
Q3 | $2.73M | Hold |
3,854
| – | – | ﹤0.01% | 3122 |
|
|
2022
Q2 | $2.72M | Hold |
3,854
| – | – | ﹤0.01% | 3193 |
|
|
2022
Q1 | $2.71M | Hold |
3,854
| – | – | ﹤0.01% | 3323 |
|
|
2021
Q4 | $2.7M | Hold |
3,854
| – | – | ﹤0.01% | 3278 |
|
|
2021
Q3 | $2.7M | Sell |
3,854
-2
| -0.1% | -$1.4K | ﹤0.01% | 3247 |
|
|
2021
Q2 | $2.68M | Buy |
+3,856
| New | +$2.68M | ﹤0.01% | 3275 |
|